Effectiveness of a Mobile App in Reducing Therapeutic TAT in an Emergency Department
NCT ID: NCT05557331
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
18 participants
INTERVENTIONAL
2025-03-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome will be the mean elapsed time in minutes between the delivery of lab results and the emergency department caregivers accessing them before (i.e., on the institutional electronic medical records) and after the implementation of the app (i.e, directly on the app).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PIMPmyHospital: a Mobile App to Improve Emergency Care Efficiency and Communication
NCT05203146
Evaluation of Mobile App to Assist in Pediatric Triage
NCT05363124
Impact of a mHealth Supportive Tool on Cardiopulmonary Resuscitation' Situational Awareness
NCT04464603
Mobile-based Social Services Screening and Referral Tool in an Pediatric Emergency Department
NCT03562910
FOllow-up of LOW-acuity Patients After REdirection From a Swiss Emergency Department Using an Electronic TRIage Application
NCT06971419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will conduct an 18-month, single center, non-equivalent comparison group, pre-post study. The study will compare the control and experimental groups on outcome measures before (12-month period) and after (6-month period) the intervention consisting of the use of the app. The study will take place in the pediatric ED of a tertiary referral and major trauma hospital in Switzerland, with an annual volume of 35,000 visits.
Eligible participants will be postgraduate residents pursuing a \<6-year residency in pediatrics, pediatric emergency medicine fellows, and registered nurses from the pediatric ED (aged \> 18 years). Written informed consent will be obtained from each participant in the interventional group after full information disclosure prior to study participation.
Before the implementation of the app, electronic medical records (EMR)-based data from the past 12 months will be collected retrospectively. These data include the times (i.e., HH:MM:SS) that results issued by the central laboratory were available on the institutional's EMR, as well as the times at which these results were accessed by caregivers via conventional computerized workstations. (ii) After the implementation of the app, data will be collected prospectively over a 6-month period of use. This will include the times (HH:MM:SS) when the results issued by the central laboratory are made available on caregivers' mobile app and access times, as well as concurrent or preferred access times on the conventional computerized workstations should this occur. Individual acceptance of the app on the first day (a priori), at 1 week, and then on the last day of the intervention (6 months) will be evaluated through the Unified Theory of Acceptance, and Use of Technology (UTAUT). Usability of the app will be measured by the System Usability Scale (SUS).
The primary outcome will be the mean elapsed time in minutes between the delivery of the lab results and the caregiver accessing them, both before and after the implementation of the app.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-intervention (no app)
Participants before (12-month retrospective period) the implementation of the app in the emergency department.
No interventions assigned to this group
Post-intervention (PIMPmyHospital app)
Participants that will use the mobile heath PIMPmyHospital app during the prospective 6-month period after the implementation of the app in the emergency department.
PIMPmyHospital (mobile app)
After the implementation of the app, data will be collected prospectively over a 6-month period of use. This will include the times (HH:MM:SS) when the results issued by the central laboratory are made available on caregivers' mobile app and access times (as well as concurrent or preferred access times on the conventional computerized workstations should this occur).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PIMPmyHospital (mobile app)
After the implementation of the app, data will be collected prospectively over a 6-month period of use. This will include the times (HH:MM:SS) when the results issued by the central laboratory are made available on caregivers' mobile app and access times (as well as concurrent or preferred access times on the conventional computerized workstations should this occur).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any pediatric emergency medicine fellows.
* To be registered nurses from the pediatric emergency department.
* Participation agreement.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pediatric Clinical Research Platform
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johan Siebert, MD
MD, Deputy Head of the Pediatric Emergency Department, Pediatric Emergency Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan N Siebert, MD
Role: STUDY_DIRECTOR
Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geneva Children's Hospital, Geneva University Hospitals
Geneva, Canton of Geneva, Switzerland
Geneva Children's Hospital, Geneva University Hospitals
Geneva, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ehrler F, Tuor C, Rey R, Siebert JN. A Mobile App to Improve Patient Management in Emergency Departments: Caregiver Needs Analysis, Design and Early Technology Acceptance Assessment. Stud Health Technol Inform. 2021 Oct 27;285:233-238. doi: 10.3233/SHTI210605.
Ehrler F, Tuor C, Trompier R, Berger A, Ramusi M, Rey R, Siebert JN. Effectiveness of a Mobile App in Reducing Therapeutic Turnaround Time and Facilitating Communication between Caregivers in a Pediatric Emergency Department: A Randomized Controlled Pilot Trial. J Pers Med. 2022 Mar 9;12(3):428. doi: 10.3390/jpm12030428.
Ehrler F, Tuor C, Rey R, Trompier R, Berger A, Ramusi M, Courvoisier DS, Siebert JN. Effectiveness of a Mobile App (PIMPmyHospital) in Reducing Therapeutic Turnaround Times in an Emergency Department: Protocol for a Pre- and Posttest Study. JMIR Res Protoc. 2023 May 3;12:e43695. doi: 10.2196/43695.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PIMPmyHospital pre-post study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.